Skip to main content
. 2023 Jul-Aug;68(4):486. doi: 10.4103/ijd.ijd_18_23

Table 5.

Association between systemic manifestations and various antinuclear antibodies

ANA antibodi es Tested results Musculos keletal system Present (%) Gastroint estinal system Present (%) Respiratory system Present (%) Cardiova scular system Present (%) Renal system Present (%) Centralnervous system Present (%)
Anti-dsDNA Positive 12 (40%) 3 (10%) 4 (13%) 1 (3%) 5 (16%) 0 (0%)
Negative 8 (26%) 7 (23%) 7 (23%) 2 (6%) 7 (23%) 7 (23%)
P 0.038* 0.196 0.386 0.626 0.654 0.005
Anti Sm Positive 4 (13%) 3 (10%) 2 (7%) 0 (0%) 6 (20%) 7 (23%)
Negative 16 (53%) 7 (23%) 9 (30%) 3 (10%) 6 (20%) 0 (0%)
P 0.243 0.77 0.424 0.271 0.018* 0.001*
Anti SCL 70 Positive 5 (16%) 4 (13%) 6 (20%) 2 (6%) 1 (3%) 0 (0%)
Negative 15 (50%) 6 (20%) 5 (16%) 1 (3%) 11 (33%) 7 (23%)
P 0.77 0.243 0.009* 0.099 0.064 0.068
Anti SS-A Positive 3 (10%) 2 (6%) 1 (3%) 2 (6%) 3 (10%) 2 (6%)
Negative 17 (57%) 8 (27%) 10 (33%) 1 (3%) 9 (30%) 5 (16%)
P 0.729 0.702 0.397 0.014* 0.317 0.334

*Indicates correlation